Search For "disease free survival"
Thyroid cancer treatment does not benefit from addition of immune modulato
Updated : 2 years, 6 months ago IST
According to the findings of a multicenter phase II clinical trial, treating people who have differentiated thyroid cancer (DTC), an advanced form of thyroid cancer that arises from thyroid follicular cells, with the targeted tyrosine kinase inhibitor (TKI) cediranib in addition to their tre
Read More
Adding immune modulator to targeted therapy does not improve thyroid cance
Updated : 2 years, 6 months ago IST
According to the findings of a multicenter phase II clinical trial, treating patients with differentiated thyroid cancer (DTC), an advanced form of thyroid cancer that arises from thyroid follicular cells, in addition to their treatment with the targeted tyrosine kinase inhibitor (TKI) cedir
Read More
Adding ribociclib to hormone therapy improves outcomes for patients with e
Updated : 2 years, 9 months ago IST
A study found that patients with early hormone-receptor (HR) positive/HER2 negative breast cancer had a significant advantage in invasive disease-free survival when ribociclib, a targeted therapy medicine, was added to hormone treatment.
Read More
Study finds how adding ribociclib to hormone therapy improves results in e
Updated : 2 years, 9 months ago IST
A study discovered that when ribociclib, a targeted therapy medicine, is added to hormone treatment, patients with early hormone-receptor (HR) positive/HER2 negative breast cancer had a substantial invasive disease-free survival advantage.
Read More